GILDC
Gilead Sciences, Inc. Shs Cert Deposito Arg Repr 1/4 Sh · BCBA:GILDC
43.22 USD4.99 +13.05%
Gilead Sciences, Inc. Shs Cert Deposito Arg Repr 1/4 Sh (BCBA:GILDC) last traded at 43.22 USD, up 13.05% on the day. Over the past year the stock is up 56.31%. Its 52-week range is 30.47 to 43.22. It is in the Health Technology sector (Biotechnology).
Key statistics
Open43.22
Day range43.22 – 43.22
52-week range30.47 – 43.22
Volume17
Average volume (10 days)13
Market cap210.29 B
EPS (TTM)−0.6871
Dividend yield1.05%
Beta (1 year)0.0546
Revenue (TTM)29.35 B
Employees17.00 K
Performance
+13.05%1 week
+15.62%1 month
+32.29%3 months
+31.05%6 months
+41.84%Year to date
+56.31%1 year
Technical reading
Strongly bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Dr. Reddy's granted FDA nod for first generic targeting Gilead’s YeztugoSeeking Alpha · 03 Nov 2026
- How health care is on the ballot in the midtermsSeeking Alpha · 03 Nov 2026
- Gilead to Present Late-Breaking Clinical Data and Real-World Evidence at HIV GlasgowBusinessWire · 02 Nov 2026
- Why Did MO, GILD, XOM Stocks Surge To 52-Week Highs Last Week?Stocktwits · 02 Nov 2026
- Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
- Gilead Sciences Is Maintained at Buy by UBSDow Jones Newswires · 31 Oct 2026
- Gilead Sciences Is Maintained at Overweight by JP MorganDow Jones Newswires · 30 Oct 2026
- Gilead Sciences Price Target Raised to $188.00/Share From $165.00 by CitigroupDow Jones Newswires · 30 Oct 2026
Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.